WaveMan · Form 4
Vaddi Krishna insider trades
> Search tickers & screens ⌘K
LIVE

Vaddi Krishna insider trades

Vaddi Krishna has filed 17 Form 4s with the SEC that we hold, all for Prelude Therapeutics Inc (PRLD), as CEO, Director. Across all of them we count 15 purchases worth $871.9K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 675,000 shares of Prelude Therapeutics Inc worth $465.7K, dated 2025-03-25. The first filing on our record is dated 2021-07-22 and the latest 2026-02-05.

Prelude Therapeutics Inc (PRLD)

CEO, Director · 17 filings · 15 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-12-20P, purchase reported on Form 419,188$98.4K2022-12-21
2023-05-23P, purchase reported on Form 411,856$66.7K2023-05-25
2023-05-24P, purchase reported on Form 41,000$5.0K2023-05-26
2023-05-25P, purchase reported on Form 4900$4.8K2023-05-26
2024-12-18P, purchase reported on Form 4100,000$93.0K2024-12-20
2024-12-19P, purchase reported on Form 46,888$6.1K2024-12-20
2024-12-30P, purchase reported on Form 410,000$12.0K2025-01-02
2024-12-31P, purchase reported on Form 45,000$6.0K2025-01-03
2025-03-12P, purchase reported on Form 447,500$33.7K2025-03-14
2025-03-13P, purchase reported on Form 450,000$36.0K2025-03-14
2025-03-14P, purchase reported on Form 429,999$22.5K2025-03-18
2025-03-17P, purchase reported on Form 49,106$6.8K2025-03-18
2025-03-20P, purchase reported on Form 45,416$4.0K2025-03-24
2025-03-21P, purchase reported on Form 415,000$10.9K2025-03-24
2025-03-25P, purchase reported on Form 4675,000$465.7K2025-03-27
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1824633) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms